558 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Jun 24
Departure of Directors or Certain Officers
4:02pm
and independent contractors of the Company and to the Company’s non-employee directors. In addition, the following annual limitations apply: (i) no one … of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
to be an independent Director in accordance with any national securities exchange on which the corporation’s securities are listed.
(c) A candidate … , independent accountants or other persons as to matters which the Director or executive officer believed to be within such person's professional
S-8
EX-23.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
1 Mar 24
Registration of securities for employees
4:09pm
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement
S-8
oqne3p55
1 Mar 24
Registration of securities for employees
4:09pm
8-K
EX-10.1
37p2rispr
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
ktgjn03m6g 508j
27 Sep 23
Departure of Directors or Certain Officers
8:38am
8-K
auf8a
9 Jun 23
Submission of Matters to a Vote of Security Holders
5:00pm